Neuralstem - Investors - Investor FAQs

Q. Where is Neuralstem’s stock traded?

A. Neuralstem’s shares are traded on the NASDAQ Stock Market under the symbol “CUR.”

Q. When did the company go public?

A. Neuralstem went public in December 2006.

Q. Where are Neuralstem‘s headquarters located?

A. Neuralstem, Inc.
20271 Goldenrod Lane, 2nd Floor
Germantown, MD 20876
Phone: 301.366.4960

Q. When do Neuralstem’s fiscal quarters end?

A. First Quarter: March 31
Second Quarter: June 30
Third Quarter: September 30
Fourth Quarter: December 31

Q. Who is Neuralstem’s independent auditor?

A. Stegman & Company
405 East Joppa Road
Baltimore, MD 21286

Q. How can I buy Neuralstem stock?

A. You may purchase CUR stock through a registered stockbroker.

Q. Does Neuralstem have a direct stock purchase plan?

A. No. Shares can be purchased through a registered or discount stock brokerage firm.

Q. Whom should I contact with questions about my stock ownership?

A. Beneficial shareholders with shares held by a broker in the name of the brokerage house should contact their broker on all administrative matters. If you are a registered shareholder and have questions regarding your account status (e.g. number of shares, missing certificates, address changes, etc.), please contact Neuralstem’s transfer agent.

Q. Who is Neuralstem’s transfer agent?

A. American Stock Transfer & Trust Co.
59 Maiden Lane
Plaza Level
New York, NY 10038
Phone: 800.937.5449

Q. Where can I find financial information about Neuralstem?

A. Neuralstem files periodic reports, including Annual Reports (Form 10-K), Quarterly Reports (Form 10-Q) and Current Reports (Form 8-K) with the Securities and Exchange Commission (SEC). These reports are available on our SEC Filings page, or at www.sec.gov. In addition, Neuralstem posts recent financial information in the form of quarterly earnings press releases here on the Press Releases page.

Q. How can I sign up to receive Neuralstem's press releases and other company information?

A. Click here to be added to Neuralstem’s distribution list.

Q. Whom should I contact if I have more questions about investing in Neuralstem?

A. Investor Relations
Danielle Spangler - Neuralstem, Inc.
Phone: 301.366.1481

David Castaneda - MDC Group
Phone: 414.351.9758

Q. Who is Neuralstem’s PR contact?

A. Planet Communications
Deanne Eagle
Phone: 917.837.5866, deanneeagle@gmail.com

Investor FAQs

Information for Investors